Pediatrix Medical Group, Inc.
Financials
Valuation Metrics
Pediatrix Medical Group, Inc.'s Market Cap is $2.15B. At end of 2025 it was $1.81B. Ranked #2000 of 3,112 in US market (top 64%), #1243 of 1,667 on NYSE (top 75%), #117 of 206 in Health Care Equipment & Services (top 57%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.15B | US#2,000/3,112 Sec#117/206 |
| Revenue | $1.93B | US#1,500/3,112 Sec#93/206 |
| Net Income | $174M | US#1,332/3,112 Sec#63/206 |
| Total Assets | $2.07B | US#2,037/3,112 Sec#102/206 |
| Net Assets | $879M | US#1,865/3,112 Sec#98/206 |
| Employees | 4,280 | US#900/3,112 Sec#76/206 |
| Value | ||
| P/E | 12.36x | US#435/3,112 Sec#10/206 |
| P/B | 2.45x | US#1,449/3,112 Sec#81/206 |
| PEG | 0.29x | US#404/3,112 Sec#12/206 |
| P/S | 1.12x | US#733/3,112 Sec#50/206 |
| EV/EBITDA | 9.24x | US#644/3,112 Sec#22/206 |
| FCF Yield | 11.03% | US#426/3,112 Sec#14/206 |
| Profitability | ||
| ROE | 19.83% | US#583/3,112 Sec#29/206 |
| ROA | 8.42% | US#578/3,112 Sec#33/206 |
| Op. Margin | 11.86% | US#1,473/3,112 Sec#66/206 |
| Revenue Growth | 3.89% | US#1,863/3,112 Sec#140/206 |
| Earnings Growth | 42.60% | US#620/3,112 Sec#25/206 |
| Financial Health | ||
| Debt Ratio | 135.64% | US#1,384/3,112 Sec#132/206 |
| Total Debt | $630M | US#1,701/3,112 Sec#94/206 |
| FCF | $238M | US#1,259/3,112 Sec#74/206 |
| Cash | $206M | US#1,704/3,112 Sec#99/206 |
| Current Ratio | 1.33x | US#1,850/3,112 Sec#167/206 |
| Net Debt/EBITDA | 1.52x | US#1,209/3,112 Sec#66/206 |
| Performance | ||
| 1Y Return | 118.95% | US#251/3,112 Sec#22/206 |
| 1M Return | -1.98% | US#1,915/3,112 Sec#129/206 |
| From 52W High | -6.12% | US#673/3,112 Sec#45/206 |
| 1Y MDD | -23.65% | US#938/3,112 Sec#18/206 |
| Trading | ||
| Volume | 555,856 shares | US#1,987/3,112 Sec#145/206 |
| Trading Value | $15M | US#2,141/3,112 Sec#145/206 |
| Per Share | ||
| EPS | $1.96 | US#1,284/3,112 Sec#68/206 |
| BPS | $10.26 | US#1,764/3,112 Sec#104/206 |
Company Info
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.